Investors

Elasmogen is a privately held drug discovery and development, biopharmaceutical company founded in 2016 and located in the thriving biologics cluster in Aberdeen, Scotland.

We are proud to have the backing and support of our investors; Deepbridge Capital LLP, BGF, the Scottish National Investment Bank and Scottish Enterprise.